Cargando…
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Spondyloarthritis (SpA) represents a family of inflammatory diseases of the spine and peripheral joints. Ankylosing spondylitis (AS) is the prototypic form of SpA in which progressive disease can lead to fusion of the spine. Therapeutically, knowledge of type 3 immunity has translated into the devel...
Autores principales: | Gracey, Eric, Hromadová, Dominika, Lim, Melissa, Qaiyum, Zoya, Zeng, Michael, Yao, Yuchen, Srinath, Archita, Baglaenko, Yuriy, Yeremenko, Natalia, Westlin, William, Masse, Craig, Müller, Mathias, Strobl, Birgit, Miao, Wenyan, Inman, Robert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108927/ https://www.ncbi.nlm.nih.gov/pubmed/32149730 http://dx.doi.org/10.1172/JCI126567 |
Ejemplares similares
-
From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases
por: Hromadová, Dominika, et al.
Publicado: (2021) -
TYK2 in Tumor Immunosurveillance
por: Karjalainen, Anzhelika, et al.
Publicado: (2020) -
TYK2: An Upstream Kinase of STATs in Cancer
por: Wöss, Katharina, et al.
Publicado: (2019) -
In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
por: Prchal-Murphy, Michaela, et al.
Publicado: (2015) -
Tyk2 is a tumor suppressor in colorectal cancer
por: Moritsch, Stefan, et al.
Publicado: (2022)